n-(2,6-bis(isopropyl)phenyl)-n'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea has been researched along with Adrenal Gland Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augelli-Szafran, CE; Bousley, RF; Essenburg, AD; Hamelehle, KL; Holmes, A; Krause, BR; Purchase, TS; Stanfield, RL; Trivedi, BK | 1 |
1 other study(ies) available for n-(2,6-bis(isopropyl)phenyl)-n'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea and Adrenal Gland Diseases
| Article | Year |
|---|---|
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
Topics: Adrenal Gland Diseases; Animals; Anticholesteremic Agents; Cholesterol; Guinea Pigs; Male; Molecular Structure; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Structure-Activity Relationship | 1994 |